Georgia Erbez

Georgia Erbez

Chief Financial Officer and Chief Business OfficeratCodexis· In proxies 2024–2025

Pay in FY2025+45% from the year before · Codexis stock -65.8% the same year

Georgia Erbez was paid $1.4M in FY2025 (Dec), up 45%. Codexis stock fell 65.8% that year.

Pay$100 in the stock at the end of FY23 → $53
Pay is from the Summary Compensation Table of each Codexis proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. CodexisPublic company · 2 yr
    • Chief Financial Officer and Chief Business Officer2024 – Present · 2 yrStock in role -62%
  2. Coherus OncologyPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  3. AltiBio, Inc.Public company · 5 yr
    • Director2018 – 2023 · 5 yrNo stock prices for these years
  4. Sierra Oncology, Inc.Public company · 1 yr
    • Director2021 – 2022 · 1 yrNo stock prices for these years
  5. Artelo Biosciences, Inc.Public company · 2 yr
    • Director2017 – 2019 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • Coherus OncologyDirector · 0 yr on the boardIndependentAudit—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?